medroxyprogesterone acetate has been researched along with Active Hyperemia in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (66.67) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Lerner, JL; McBrayer, JD; Miller, LA; Shala, BA; Sullivan, JM | 1 |
Chayama, K; Higashi, Y; Kimura, M; Kodama, I; Nakagawa, K; Ohama, K; Sanada, M; Tsuda, M | 1 |
Akay, HO; Bahceci, M; Gokalp, D; Pasa, S; Tumer, C; Tuzcu, A | 1 |
1 trial(s) available for medroxyprogesterone acetate and Active Hyperemia
Article | Year |
---|---|
Serum nitric oxide levels and flow-mediated dilatation in patients with Sheehan syndrome and the effect of combination therapy consisting of L-thyroxine, prednisolone, and conjugated estrogen/medroxyprogesterone acetate.
Topics: Adult; Brachial Artery; Drug Therapy, Combination; Estrogens, Conjugated (USP); Female; Humans; Hyperemia; Hypopituitarism; Medroxyprogesterone Acetate; Middle Aged; Nitric Oxide; Prednisolone; Thyroxine; Treatment Outcome; Ultrasonography; Vasodilation | 2008 |
2 other study(ies) available for medroxyprogesterone acetate and Active Hyperemia
Article | Year |
---|---|
Progestin enhances vasoconstrictor responses in postmenopausal women receiving estrogen replacement therapy.
Topics: Administration, Intravenous; Administration, Oral; Adult; Cold Temperature; Drug Therapy, Combination; Estrogen Replacement Therapy; Estrogens; Estrogens, Conjugated (USP); Female; Follicle Stimulating Hormone; Forearm; Humans; Hyperemia; Luteinizing Hormone; Medroxyprogesterone Acetate; Middle Aged; Postmenopause; Progestins; Regional Blood Flow; Rest; Vascular Capacitance; Vascular Resistance; Vasoconstriction | 2018 |
Hormone replacement effects on endothelial function measured in the forearm resistance artery in normocholesterolemic and hypercholesterolemic postmenopausal women.
Topics: Arteries; Blood Flow Velocity; Cholesterol, HDL; Cholesterol, LDL; Endothelium, Vascular; Estradiol; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Forearm; Humans; Hypercholesterolemia; Hyperemia; Lipids; Medroxyprogesterone Acetate; Middle Aged; Nitrates; Nitrites; Nitroglycerin; Peptidyl-Dipeptidase A; Plethysmography; Postmenopause; Vascular Resistance | 2002 |